Processa Pharmaceuticals, Inc. - 10-Q Filing

Processa Pharmaceuticals enters merger agreement with Vidya Therapeutics, Inc. involving Series A Preferred Stock issuance.

SEC EDGAR ·

Tickers: $PCSA

Read the full article at SEC EDGAR

More Regulatory news